BNTC analyst estimates
Benitec Biopharma (BNTC) analyst ratings, the average price target and its range, and every firm's latest call.
- 2 firms rate BNTC: 2 buy, 0 hold, 0 sell.
- The average price target is $17.00 from None analysts, from $14.00 to $20.00.
BNTC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 16, 2026 | Wedbush | Benitec BioPharma (BNTC) PT Raised to $20 at Wedbush | $20.00 |
| Oct 23, 2026 | Raymond James | Raymond James Starts Benitec BioPharma (BNTC) at Outperform | $14.00 |
| Sep 15, 2026 | Wedbush | Benitec Biopharma price target raised to $17 from $16 at Wedbush | $17.00 |
| Jul 28, 2026 | Wedbush | Benitec Biopharma initiated with an Outperform at Wedbush | $16.00 |
| May 12, 2026 | Evercore ISI | Benitec Biopharma initiated with an Outperform at Evercore ISI | $25.00 |
| Nov 24, 2025 | H.C. Wainwright | Benitec Biopharma price target lowered to $32 from $35 at H.C. Wainwright | $32.00 |
| Nov 4, 2025 | JMP Securities | Benitec Biopharma price target raised to $22 from $20 at Citizens JMP | $22.00 |
| Nov 4, 2025 | H.C. Wainwright | Benitec Biopharma price target raised to $35 from $28 at H.C. Wainwright | $35.00 |
| Sep 16, 2025 | Oppenheimer | Benitec Biopharma price target lowered to $29 from $35 at Oppenheimer | $29.00 |
| Oct 14, 2024 | Leerink Partners | Leerink Partners Reiterates Outperform Rating on Benitec BioPharma (BNTC) | $13.00 |
| Oct 14, 2024 | JMP Securities | Benitec Biopharma price target lowered to $16 from $18 at JMP Securities | $16.00 |
| Oct 14, 2024 | JMP Securities | Benitec Biopharma price target raised to $18 from $16 at JMP Securities | $18.00 |
| Sep 24, 2024 | Piper Sandler | Piper Sandler Reiterates Overweight Rating on Benitec BioPharma (BNTC) | $30.00 |